ESSA Pharma Inc. (EPIX)
Largest Insider Buys in Sector
EPIX Stock Price History Chart
EPIX Stock Performance
About ESSA Pharma Inc.
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.
Insider Activity of ESSA Pharma Inc.
Over the last 12 months, insiders at ESSA Pharma Inc. have bought $574,148 and sold $798,400 worth of ESSA Pharma Inc. stock.
On average, over the past 5 years, insiders at ESSA Pharma Inc. have bought $3.64M and sold $558,126 worth of stock each year.
Highest buying activity among insiders over the last 12 months: BERGER FRANKLIN M (director) — $1.66M. Parkinson David Ross (Chief Executive Officer) — $21,213.
The last purchase of 9,223 shares for transaction amount of $21,213 was made by Parkinson David Ross (Chief Executive Officer) on 2023‑12‑14.
List of Insider Buy and Sell Transactions, ESSA Pharma Inc.
| 2024-05-06 | Sale | Virsik Peter | Chief Operating Officer | 694 0.0016% | $6.95 | $4,823 | -15.19% | |
| 2024-04-05 | Sale | Virsik Peter | Chief Operating Officer | 694 0.0015% | $7.94 | $5,510 | -25.54% | |
| 2024-03-05 | Sale | Virsik Peter | Chief Operating Officer | 694 0.0015% | $8.98 | $6,232 | -27.32% | |
| 2024-02-06 | Sale | Virsik Peter | Chief Operating Officer | 72,782 0.2007% | $10.29 | $748,927 | -31.40% | |
| 2024-02-05 | Sale | Virsik Peter | Chief Operating Officer | 1,194 0.0031% | $9.58 | $11,440 | -26.17% | |
| 2024-01-16 | Sale | Virsik Peter | Chief Operating Officer | 1,718 0.0043% | $10.01 | $17,197 | -14.25% | |
| 2024-01-05 | Sale | Virsik Peter | Chief Operating Officer | 699 0.0015% | $6.11 | $4,271 | +27.83% | |
| 2023-12-14 | Parkinson David Ross | Chief Executive Officer | 9,223 0.0081% | $2.30 | $21,213 | +23.37% | ||
| 2023-11-21 | BERGER FRANKLIN M | director | 23,259 0.0523% | $5.73 | $133,274 | +18.42% | ||
| 2023-11-03 | BERGER FRANKLIN M | director | 16,471 0.0373% | $5.99 | $98,661 | +12.00% | ||
| 2023-11-02 | BERGER FRANKLIN M | director | 60,000 0.1371% | $5.35 | $321,000 | +24.95% | ||
| 2022-12-30 | Parkinson David Ross | Chief Executive Officer | 3,067 0.0072% | $2.60 | $7,974 | +17.06% | ||
| 2022-12-30 | Wood David S. | Chief Financial Officer | 8,302 0.0194% | $2.60 | $21,585 | +17.06% | ||
| 2022-12-22 | Parkinson David Ross | Chief Executive Officer | 21,367 0.0493% | $2.39 | $51,067 | +25.11% | ||
| 2022-12-21 | Sale | BERGER FRANKLIN M | director | 72,223 0.1656% | $2.41 | $174,401 | +23.01% | |
| 2022-12-20 | Sale | BERGER FRANKLIN M | director | 43,617 0.0986% | $2.53 | $110,351 | +15.75% | |
| 2022-12-16 | Sale | BERGER FRANKLIN M | director | 50,000 0.1156% | $2.67 | $133,500 | +12.21% | |
| 2022-12-15 | Sale | BERGER FRANKLIN M | director | 82,000 0.1884% | $2.88 | $235,800 | +3.52% | |
| 2022-12-14 | Sale | BERGER FRANKLIN M | director | 25,000 0.0569% | $3.00 | $75,000 | -1.67% | |
| 2022-10-27 | BIOTECH GROWTH N V | director | 500,000 1.1742% | $4.50 | $2.25M | -32.41% |
Insider Historical Profitability
| BERGER FRANKLIN M | director | 784404 1.777% | $4.99 | 4 | 5 | <0.0001% |
| Parkinson David Ross | Chief Executive Officer | 65675 0.1488% | $4.99 | 4 | 0 | +11.41% |
| Virsik Peter | Chief Operating Officer | 11246 0.0302% | $4.99 | 0 | 7 | |
| BIOTECH GROWTH N V | director | 7879583 17.8505% | $4.99 | 3 | 0 | <0.0001% |
| BB BIOTECH AG | 5879583 13.3197% | $4.99 | 2 | 1 | <0.0001% | |
| Wood David S. | Chief Financial Officer | 33343 0.0755% | $4.99 | 1 | 0 | +17.06% |
Institutional Investor Ownership
| Bvf Inc Il | $74.28M | 19.72 | 8.75M | 0% | +$0 | 0.55 | |
| Bellevue Group | $66.98M | 17.78 | 7.89M | -0.11% | -$76,410.00 | 1.02 | |
| Morgan Stanley | $35.48M | 9.42 | 4.18M | -0.19% | -$68,174.70 | <0.01 | |
| Soleus Capital Management, L.P. | $30.48M | 8.09 | 3.59M | -17.05% | -$6.27M | 0.29 | |
| PFM Health Sciences | $25.3M | 6.72 | 2.98M | -8.65% | -$2.39M | 0.7 | |
| RTW Investments, LP | $19.52M | 5.18 | 2.3M | 0% | +$0 | 0.29 | |
| Adage Capital Partners Gp L L C | $13.42M | 3.56 | 1.58M | +39.13% | +$3.77M | 0.02 | |
| Janus Henderson | $9.98M | 2.65 | 1.18M | +7.87% | +$728,102.43 | 0.01 | |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | $7.74M | 2.06 | 911,820 | +155.77% | +$4.71M | 0.74 | |
| ROCK SPRINGS CAPITAL MANAGEMENT, LP | $5.75M | 1.53 | 677,005 | 0% | +$0 | 0.15 | |
| Schonfeld Group | $3.13M | 0.83 | 368,500 | New | +$3.13M | 0.02 | |
| Parkman Healthcare Partners Llc | $2.14M | 0.57 | 251,695 | New | +$2.14M | 0.26 | |
| CIBC World Markets | $686,000.00 | 0.18 | 80,857 | -27.61% | -$261,675.53 | <0.01 | |
| D. E. Shaw & Co. | $552,538.00 | 0.15 | 65,081 | -67.4% | -$1.14M | <0.01 | |
| American Century Investments | $392,034.00 | 0.1 | 46,176 | +130.37% | +$221,860.54 | <0.0001 | |
| Citadel Advisors LLC | $310,038.00 | 0.08 | 36,518 | -86.15% | -$1.93M | <0.0001 | |
| Royal Bank of Canada | $262,000.00 | 0.07 | 30,775 | 0% | +$0 | <0.0001 | |
| Geode Capital Management | $228,024.00 | 0.06 | 26,858 | 0% | +$0 | <0.0001 | |
| Millennium Management LLC | $119,301.00 | 0.03 | 14,052 | New | +$119,301.00 | <0.0001 | |
| Advisor Group Holdings Inc | $50,940.00 | 0.01 | 6,000 | 0% | +$0 | <0.0001 | |
| BlackRock | $47,620.00 | 0.01 | 5,609 | -26.94% | -$17,557.17 | <0.0001 | |
| Simplex Trading Llc | $36,000.00 | 0.01 | 4,329 | +3.52% | +$1,222.45 | <0.01 | |
| UBS | $30,785.00 | 0.01 | 3,626 | -25.92% | -$10,773.90 | <0.0001 | |
| Cibc Private Wealth Group Llc | $21,050.00 | 0.01 | 2,500 | New | +$21,050.00 | <0.0001 | |
| Laurel Wealth Advisors Llc | $5,094.00 | <0.01 | 600 | 0% | +$0 | <0.01 | |
| JPMorgan Chase | $178.00 | <0.01 | 21 | 0% | +$0 | <0.0001 | |
| Toronto-Dominion Bank | $408.00 | <0.01 | 48 | 0% | +$0 | <0.0001 | |
| Bank of America | $68.00 | <0.01 | 8 | 0% | +$0 | <0.0001 |